Sec Form 4 Filing - Pahwa Sudhir K @ Steris plc - 2015-11-02

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Pahwa Sudhir K
2. Issuer Name and Ticker or Trading Symbol
Steris plc [ STE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Sr. V.P., IPT
(Last) (First) (Middle)
C/O CHANCERY HOUSE, 190 WATERSIDE ROAD, HAMILTON INDUSTRIAL PARK
3. Date of Earliest Transaction (MM/DD/YY)
11/02/2015
(Street)
LEICESTER, X0LE5 1QZ
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, ?0.10 Nominal Value 11/02/2015 A 21,288.7296 ( 1 ) A 21,288.7296 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 22.83 11/02/2015 A 3,000 ( 3 ) 05/21/2019 Ordinary Shares, ?0.10 Nominal Value 3,000 ( 3 ) 3,000 D
Employee Stock Option (right to buy) $ 31.87 11/02/2015 A 6,825 ( 4 ) 05/20/2020 Ordinary Shares, ?0.10 Nominal Value 6,825 ( 4 ) 6,825 D
Employee Stock Option (right to buy) $ 36.09 11/02/2015 A 6,000 ( 5 ) 05/31/2021 Ordinary Shares, ?0.10 Nominal Value 6,000 ( 5 ) 6,000 D
Employee Stock Option (right to buy) $ 29.94 11/02/2015 A 7,000 ( 6 ) 05/30/2022 Ordinary Shares, ?0.10 Nominal Value 7,000 ( 6 ) 7,000 D
Employee Stock Option (right to buy) $ 45.34 11/02/2015 A 9,552 ( 7 ) 05/31/2023 Ordinary Shares, ?0.10 Nominal Value 9,552 ( 7 ) 9,552 D
Employee Stock Option (right to buy) $ 53.52 11/02/2015 A 17,500 ( 8 ) 05/30/2024 Ordinary Shares, ?0.10 Nominal Value 17,500 ( 8 ) 17,500 D
Employee Stock Option (right to buy) $ 67.98 11/02/2015 A 18,000 ( 9 ) 08/10/2025 Ordinary Shares, ?0.10 Nominal Value 18,000 ( 9 ) 18,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Pahwa Sudhir K
C/O CHANCERY HOUSE, 190 WATERSIDE ROAD
HAMILTON INDUSTRIAL PARK
LEICESTER, X0LE5 1QZ
Sr. V.P., IPT
Signatures
/s/ Dennis P. Patton, Authorized Representative under Power of Attorney 11/02/2015
Signature of Reporting Person Date
Explanation of Responses:
( 1 )8,650 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,250 on May 31, 2016; 1,075 on May 31, 2016; 1,075 on May 31, 2017; 750 on May 30, 2016; 750 on May 30, 2017; 750 on May 30, 2018; 750 on May 30, 2016; 750 on May 29, 2017; 750 on May 28,2018 and 750 on May 28, 2019. 2,027.6908 of these Common Shares are jointly held by the Reporting Person and his spouse in a joint brokerage account.
( 2 )Represents ordinary shares of STERIS plc ("New STERIS") acquired pursuant to merger of a wholly-owned subsidiary of New STERIS with and into STERIS Corporation ("STERIS"), with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for common shares of STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
( 3 )This option to purchase 3,000 New STERIS ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,000 STERIS common shares for $22.83 per share, subject to the same terms and conditions as the original STERIS stock option.
( 4 )This option to purchase 6,825 New STERIS ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 6,825 STERIS common shares for $31.87 per share, subject to the same terms and conditions as the original STERIS stock option.
( 5 )This option to purchase 6,000 New STERIS ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 6,000 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS stock option.
( 6 )This option became or will become exercisable as follows: 1,750 on May 30, 2013; 1,750 on May 30, 2014; 1,750 on May 30, 2015 and 1,750 on May 30, 2016. This option was received in the Merger in exchange for an option to purchase 7,000 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS stock option.
( 7 )This option became or will become exercisable as follows: 2,388 on May 31, 2014; 2,388 on May 31, 2015; 2,388 on May 31, 2016 and 2,388 on May 31, 2017. This option was received in the Merger in exchange for an option to purchase 9,552 STERIS common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS stock option.
( 8 )This option became or will become exercisable as follows: 4,375 on May 30, 2015; 4,375 on May 30, 2016; 4,375 on May 30, 2017 and 4,375 on May 30, 2018. This option was received in the Merger in exchange for an option to purchase 17,500 STERIS common shares for $53.52 per share, subject to the same terms and conditions as the original STERIS stock option.
( 9 )This option will become exercisable as follows: 4,500 on May 28, 2016; 4,500 on May 28, 2017; 4,500 on May 28, 2018 and 4,500 on May 28, 2019. This option was received in the Merger in exchange for an option to purchase 18,000 STERIS common shares for $67.98 per share, subject to the same terms and conditions as the original STERIS stock option.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.